Can Latuda (lurasidone) worsen restless leg syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lurasidone Can Worsen Restless Legs Syndrome

Yes, Latuda (lurasidone) can worsen restless legs syndrome (RLS) because it is a dopamine antagonist (antipsychotic) medication, and dopamine antagonists are known to exacerbate RLS symptoms. 1

Mechanism of Worsening

  • Lurasidone is an antipsychotic that blocks dopamine receptors, and dopamine antagonism is a well-established mechanism for triggering or worsening RLS 1
  • The FDA label for lurasidone (Latuda) specifically lists "restlessness" as an adverse reaction occurring in clinical trials at rates higher than placebo (4% vs <1%) 2
  • Antipsychotics are specifically mentioned in guidelines as medications that can exacerbate RLS symptoms 1

Evidence from Guidelines

  • The American Academy of Sleep Medicine guidelines identify "dopamine antagonists (antipsychotics)" as medications that can exacerbate RLS 3
  • A variety of medications, including tricyclic antidepressants, SSRIs, lithium, and dopamine antagonists (antipsychotics) have been reported to exacerbate RLS 1
  • Drug-induced RLS is most often associated with the effect of medications on various receptors and neurotransmitter systems, in particular, the dopamine system 4

Management Recommendations

  • If a patient develops or experiences worsening of RLS while taking lurasidone, consider the following options:
  1. Assess for iron deficiency - Check serum ferritin and transferrin saturation, as iron supplementation may help mitigate RLS symptoms if ferritin ≤75 ng/mL or transferrin saturation <20% 3

  2. Consider medication alternatives if clinically appropriate:

    • Discuss with the prescribing psychiatrist whether an alternative antipsychotic with less dopamine antagonism might be suitable 1
    • If lurasidone must be continued, consider adding treatments for RLS:
      • Alpha-2-delta ligands (gabapentin, pregabalin) are first-line treatments for RLS 3
      • Iron supplementation if indicated by lab values 3
  3. Timing adjustment - If possible, administer lurasidone earlier in the day rather than in the evening to minimize nighttime RLS symptoms 3

Risk Factors for Drug-Induced RLS

  • Older age increases risk of drug-induced RLS 4
  • Gastrointestinal diseases can increase risk 4
  • Higher medication doses increase likelihood of RLS symptoms 4
  • Concurrent use of multiple medications that can affect RLS (≥2 drugs) increases risk 4

Prevention and Monitoring

  • Monitor for early signs of RLS when starting lurasidone, including:

    • Urge to move the legs accompanied by uncomfortable sensations 1
    • Symptoms that begin or worsen during periods of rest 1
    • Relief with movement 1
    • Symptoms that worsen in the evening or at night 1
  • For patients already diagnosed with RLS, carefully weigh the risks and benefits of starting lurasidone, as it may significantly worsen their condition 1, 3

Remember that drug-induced RLS treatment primarily involves identifying and withdrawing the causative medication when possible, or decreasing its dosage if discontinuation is not an option 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Restless Legs Syndrome (RLS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Drug-induced restless legs syndrome].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.